Young mum pays it forward
18 February 2019
Melissa Tague, 32, first assumed a lump in her groin was an in-grown hair. But it turned out to be melanoma which had spread to her lymph nodes.
“My family has no history of cancer, and I thought melanoma was something only people with bad freckles or the elderly got. I was in complete shock,” said Melissa.
Melissa was referred to Co-Medical Director Professor Georgina Long at Melanoma Institute Australia and put on the OpACIN-Neo Clinical Trial.
On the trial she was given a combination of immunotherapies ipilimumab and nivolumab before surgery, in a bid to stop her Stage III melanoma progressing to Stage IV.
Melissa was among the 70% of trial patients who responded.
“I thought melanoma was a death sentence. I was so lucky to have the opportunity to go on this trial which has given me hope that I will see my two girls grow up.”
Melissa credits Professor Long for saving her life and is ‘paying it forward’ by participating in Melanoma March 2019 in Picton.
Join Melissa and her family at a Melanoma March near you!
“Raising funds for melanoma research ultimately ensures we are one step closer to finding a cure for melanoma,” she said. Melissa now undergoes scans every three months to ensure the melanoma hasn’t returned. The chance of recurrence is terrifying for anyone affected by melanoma.
Catch up on the latest news from Melanoma Institute Australia in our Summer edition of Momentum.